Assessing Federal Policies to Reduce Economic Barriers to Clinical Trial Enrollment
Journal of Law, Medicine & Ethics · 2025 · 53 (2) · 200-209
DOI: 10.1017/jme.2025.61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, online erschienen am 23.05.2025. Verfasst von Daniel Albert-Rozenberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quinn Emanuel Urquhart and Sullivan LLP, Boston, Massachusetts, US. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The risk of losing access to crucial means-tested programs — like Medicaid, Supplemental Security Income (SSI), the Supplemental Nutrition Assistance Program (SNAP), and Temporary Assistance for Needy Families (TANF) — poses a barrier to the enrollment of low-income Americans in clinical trials. This burden likely disproportionately affects members of racial and ethnic minority groups, people with disabilities, elderly individuals, and rural populations, and may frustrate efforts to reflect the US population in clinical trial enrollment. To help achieve representative clinical trials for myriad conditions, Congress should pass legislation excluding payments to clinical trial participants from gross income and expand the clinical trial compensation exclusions for means-tested programs established in the Ensuring Access to Clinical Trials Act of 2015.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Quinn Emanuel Urquhart and Sullivan LLP, Boston, Massachusetts, US.
- Ropes & Gray LLP, Boston, Massachusetts, US.
- Hogan Lovells, Washington, District of Columbia, US.
- Harvard Law School, Center for Health Law and Policy Innovation, Cambridge, Massachusetts, US.
- Brigham and Women's Hospital, Boston, Massachusetts, US.
- Harvard Medical School, Massachusetts, US.
ORCID-Profile: Erika Hanson, Barbara E Bierer
Zitieren
APA
Albert-Rozenberg, D., Peloquin, D., Liss, J., Hanson, E., & Bierer, B. E. (2025). Assessing Federal Policies to Reduce Economic Barriers to Clinical Trial Enrollment. Journal of Law, Medicine & Ethics, 53(2), 200-209. https://doi.org/10.1017/jme.2025.61
Vancouver
Albert-Rozenberg D, Peloquin D, Liss J, Hanson E, Bierer BE. Assessing Federal Policies to Reduce Economic Barriers to Clinical Trial Enrollment. Journal of Law, Medicine & Ethics. 2025;53(2):200-209. doi:10.1017/jme.2025.61
BibTeX
@article{AlbertRozenberg2025,
author = {Albert-Rozenberg, Daniel and Peloquin, David and Liss, Joseph and Hanson, Erika and Bierer, Barbara E},
title = {Assessing Federal Policies to Reduce Economic Barriers to Clinical Trial Enrollment},
journal = {Journal of Law, Medicine & Ethics},
year = {2025},
volume = {53},
number = {2},
pages = {200--209},
doi = {10.1017/jme.2025.61}
}
EUVIMED